Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines.
Medicine May 18, 2018
An expensive drug manufactured by Amgen will reportedly reduce the rate of heart problems. The cost of this effective cholesterol drug, however, is more than $14,000 a year.
Medicine March 19, 2017
Amgen's drug Repatha can shrink artery-clogging plaques when used together with statin. The combo also leads to a significant reduction in bad cholesterol levels among heart patients.
Medicine November 16, 2016
DeCODE genetics, an Amgen-owned company, claimed it has identified a new genetic variant involving the ASGR1 gene, a finding that can reduce heart disease risk by 35 percent.
Medicine May 19, 2016
Amgen pioneered in establishing a platform for failed efforts in replicating studies. This will allow companies and academic researchers to share replications to others so it will prevent them from wasting time and effort on following up flawed findings.
Life February 5, 2016
Amgen's Repatha has been turned down for NHS funding by NICE. The UK cost watchdog said that analyses presented for the anti-cholesterol drug exhibited a high level of uncertainty, and thus cannot be recommended for use in Britain's state health.
Life November 19, 2015
Amgen's Melanoma drug made history as the first drug of its kind to get an FDA approval. The drug uses a genetically engineered herpes virus to attack tumors using an immune system compound.
Life October 28, 2015
Drug regulators from the European Medicines Agency have issued a recommendation for the approval of Amgen's virus-based cancer treatment, T-Vec. If approved by the European Commission, T-Vec would become the first drug in a class of novel agents called oncolytic immunotherapies.
Life October 24, 2015
Express Scripts announced that they will be paying for Amgen and Regeneron/Sanofi's costly cholesterol drugs for their members. The company said they were able to negotiate the best prices and thus is now confident in providing the medicines under certain conditions.
Life October 8, 2015
New drug works differently from statins to lower 'bad' LDL cholesterol. Approval could bring billions into Amgen's coffers.
Life August 29, 2015
Amgen Inc. decided to pay 47 states with $71 million as settlement for off-label promotions that it has been accused of for two of its products. According to the charges, the pharmaceutical company has advertised Enbrel and Aranesp outside of FDA's recommendations.
Life August 19, 2015
Amgen's Repatha has received the greenlight from the European Commission as treatment for those with uncontrolled cholesterol who require additional reduction in LDL.
Life July 21, 2015
Patients with migraines may soon find relief as a new class of drug shows promising effects for the prevention of an attack even before it happens. Pharmaceutical companies have presented to the American Headache Society's annual Scientific Meeting and all of them demonstrated favorable study results.
Life June 18, 2015
Members of an FDA panel urge the agency to approve Repatha. The drug made by Amgen is said to significantly lower LDL or "bad" cholesterol.
Life June 12, 2015
PCSK9 inhibitors can lower bad cholesterol level to extremely low levels and do not come with side effects associated with statins. The new drugs, however, can cost $10,000 per year which can have significant effect on healthcare.
Life June 9, 2015
By summer, Americans could be enjoying two new drugs in different doses designed to effectively lower levels of bad cholesterol in the body and improve health management.
Life May 27, 2015
In a study, Amgen drug Kyprolis outperformed Takeda’s Velcade in efficacy as treament for relapsed multiple myeloma in combination with low-dose dexamethasone.
Life March 2, 2015
For $178,000, Blincyto features a two-month treatment period. It’s definitely one of the more expensive immunotherapy cancer treatments around but Amgen counters it’s worth it.
Life December 20, 2014
It’s always a good thing to have other options. Novartis’ version of Neupogen appears to be just as effective as the original, providing breast cancer patients with neutropenia other choices to consider.
Life December 8, 2014
Ovarian cancer drug fails to improve overall survival rate in clinical trial. Amgen announces results of late-stage trial of drug trebananib.
Life November 4, 2014
Kyprolis, Amgen’s drug for patients with multiple myeloma, has demonstrated pharmacological benefits in its third stage of clinical trials.
Life August 5, 2014
The new brodalumab drug from Amgen is effective in reducing the symptoms and signs of psoriatic arthritis. The effectiveness of the antibody is advocated by a new Phase 2 study.
Life June 15, 2014
An experimental drug developed by Amgen Inc. may soon provide an alternative and possibly even a better option for people who do not get much from taking Lipitor or cannot simply tolerate the drug.
Life April 1, 2014
Drug companies are already working on programs that would develop drugs based on a study which found a genetic mutation that decreases one's risks of Type 2 Diabetes.
Life March 3, 2014